About CR Bard
CR Bard is a company based in Murray (United States) founded in 1907 was acquired by Becton Dickinson in April 2017. The company has 125 employees as of April 05, 2024. CR Bard has completed 17 acquisitions, including Amertek Medical, Angiomed and ClearStream.
- Headquarter Murray, United States
- Employees 125 as on 05 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bard India Healthcare Private Limited
- Date of Incorporation 07 Oct, 2004
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$31.73 M (USD)31.65as on Mar 31, 2023
-
Net Profit
$663 K (USD)-22.4as on Mar 31, 2023
-
EBITDA
$1.2 M (USD)5.03as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
125
as on Apr 05, 2024
-
Investments & Acquisitions
Amertek Medical
& 16 more
-
Acquired by
Becton Dickinson
(Apr 23, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of CR Bard
Unlock access to complete
Unlock access to complete
Software Development Team
289 people
Leadership Team
174 people
Sales and Marketing
153 people
Product Management Team
47 people
Senior Team
43 people
Operations Team
22 people
Human Resources and Administration
16 people
Sr. Team
15 people
Unlock access to complete
Funding Insights of CR Bard
Detailed funding history for CR Bard
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CR Bard
CR Bard has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BD is recognized for providing innovative medical technology solutions.
|
Locked | Locked | Locked |
Investor details for CR Bard
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CR Bard
CR Bard has strategically engaged in corporate development activities, having acquired 17 companies. Notable acquisitions include Amertek Medical, Angiomed and ClearStream.
Investment portfolio details for CR Bard
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A vascular embolization device is developed for peripheral procedures.
|
Locked | Locked | 2012 | Locked | |
|
Urine is captured non-invasively from incontinent adult females.
|
Locked | Locked | 2012 | Locked | |
|
Absorbable surgical sealants and hemostats are developed for leakage prevention.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for CR Bard
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CR Bard
Detailed financials for CR Bard
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cr Bard Comparisons
Peer comparison for CR Bard
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CR Bard
Detailed competitors of CR Bard
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cr Bard
Complete news archive for CR Bard
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CR Bard
CR Bard was founded in 1907.
CR Bard is headquartered in Murray, United States. It is registered at Murray, Kentucky, United States.
As of Apr 05, 2024, the latest employee count at CR Bard is 125.
Annual revenue of CR Bard is $31.73M as on Mar 31, 2023.
C. R. Bard, Inc., now branded simply as Bard, is a leading multinational developer, manufacturer, and marketer of medical technologies in the fields of vascular, urology, oncology, and surgical specialties. Bard markets its products and services worldwide to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. A company with approximately 14,000 employees, Bard is perhaps best known for having introduced the Foley catheter. Bard began negotiations to settle nearly 30,000 legal claims related to implantable vaginal meshes made by the company.
CR Bard has made 17 acquisitions, including Amertek Medical, Angiomed, and ClearStream.
CR Bard has 1 investor. Key investors include BD.